Abstract
A large number of lung cancers contains and releases a variety of neuropeptides such as adrenocorticotropic hormone (ACTH) and β-endorphin (β-EP). Although the plasma levels of these peptides have been extensively investigated as possible markers that may help in the early diagnosis of the disease, the data collected have shown their limited clinical usefulness. The present study was undertaken to evaluate whether corticotropin-releasing hormone (CRH), ACTH or β-EP levels in thebronchoalveolar lavage (BAL) fluid of patients with lung cancer might have been more helpful. To accomplish this, bronchial lavages were carried out in 25 patients affected by lung cancer (17 squamous carcinomas, 4 adenocarcinomas, 2 small cell carcinomas, and 2 not classified) and 18 controls. After centrifugation, BAL fluid was extracted using cartridges of SepPak C-18 and CRH, ACTH and β-EP levels were measured by radioimmunoassay. CRH and ACTH BAL levels in patients with lung cancer were not significantly different from those of controls. β-EP concentrations in the BAL fluid were about 200-fold higher than those of ACTH and showed a downward trend (p=0.08, Mann-Whitney test) in patients with cancer. No histologic tumor type was associated with particurarly elevated levels of any of the peptides measured, not even the two patients with small cell carcinoma, a tumor type which tends to release higher peptide levels. Therefore we conclude that measurements of CRH, ACTH and/or β-EP in the BAL fluid are not useful diagnostic tumor markers of lung cancer.
Similar content being viewed by others
References
Ratcliffe J.G. ACTH and related peptides in lung cancer. In: Recent Results in Cancer Research Springer-Verlag, Berlin, 1985, vol. 99, pag. 46.
Broder L.E. Hormone production by bronchogenic carcinoma: a review. Pathobiol. Ann. 9: 205, 1979
Bondy P.K., Gilby E.D. Endocrine function of small cell undifferentiated carcinoma of the lung. Cancer 50: 2147, 1982.
Bork E., Hansen M., Urdal P., Paus E., Holst J.J., Schifter S., Fenger M., Engbaek F. Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatinine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin-releasing peptide. Eur. J. Cancer Clin. Oncol. 24: 1033, 1988.
Winkelman W., Deub U., Allolio B., Hummerich W., Kaulen D., Brosch H., Guyot A., Arnold C. Adrenocorticotropin, calcitonin, and adiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types. Klin. Wochenschr. 62: 1018, 1984.
Ayvaian L.F., Schneider B., Gewirtz G., Yalow R.S. Ectopic production of big ACTH in carcinoma of the lung:its clinical usefulness as a biological marker. Am. Rev. Dis. 111: 279, 1975.
Bondy P.K. The pattern of ectopic hormone production in lung cancer. Yale J. Biol. Med. 54: 181, 1981.
Calogero A.E., Minacapilli G., Nicolosi A.M.G., Moncada M.L., Mistretta A., Latteri S.F., Polosa P., D’Agata R. Limited clinical usefulness of plasma corticotropin-releasing hormone, ACTH and β-endorphin measurements as markers of lung cancer. J. Endocrinol. Invest. 15: 581, 1992.
Torstensson S., Thoren M., Hall K. Plasma ACTH in patients with bronchogenic carcinoma. Acta Med. Scand. 207: 353, 1980.
Wolfsen A.E., Odell W.D. Pro ACTH: use for early detection of lung cancer. Am. J. Med. 66: 765, 1979.
Mountain C.F. A new international staging system for lung cancer. Chest 89: 225, 1986.
Calogero A.E., Kamilaris T.C., Gomez M.T., Johnson E.O., Tartaglia M.E., Gold P.W., Chrousos G.P. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal is through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 125: 2445, 1989.
Bagdy G., Calogero A.E., Chrousos G.P., Szemeredi K. Delayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphin. Brain Res. 489: 216, 1988.
Reynolds H.Y. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135: 250, 1987.
Smith D.L., Deshazo R.D. Bronchoalveolar lavage in asthma. An update and perspective. Am. Rev. Respir. Dis. 148: 523, 1993.
Doppman J.L., Pass H.I., Nieman L., Cutler G.B. Jr., Chrousos G.P., Loriaux D.L. Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. J. Clin. Endocrinol. Metab. 69: 1302, 1989.
Nieber K., Baumgarten C.R., Rathsack R., Furkert J., Oehme P., Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90: 646, 1992.
Hansen M., Hansen H.H. Tumor markers in the clinical management of patients with small cell lung cancer. Eur. Respir. J. 2: 700, 1989.
Calogero A.E., Norton J.A., Sheppard B.C., Listwak S.J., Cromack D.T., Wally R., Jensen R.T., Chrousos G.P. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. Metabolism 41: 839, 1992.
Aguayo S.M., Kane M.A., King T.E. Jr., Schwarz M.I., Grauer L., Miller Y.E. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J.Clin. Invest. 84: 1105, 1989.
Idell S., Garcia J.G.N., Gonzales K., McLarty J., Fair D.S. Fibrinopeptide A reactive peptides and procoagulant activity in the bronchoalveolar lavage: relationship to rheumatoid intersitial lung disease. J. Rheumatol. 16: 592, 1989.
Yamauchi K., Martinet Y., Basset P., Fells G.A., Crystal R.G. High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal respiratory tract. Am. Rev. Respir. Dis. 137: 1360, 1988.
Aguayo S.M., Kane M.A., King T.E., Jr., Miller Y.E. In vitro degradation of bombesin by human plasma, urine and bronchoalveolar lavage fluid. Clin. Res. 36: 502A, 1988 (abstract).
DeBold C.R., Nicholson W.E., Orth D.N. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 122: 2648, 1988.
Ruff M., Schiffmann E., Terrannova V., Pert C.B. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin. Immunol. Immunopathol. 37: 387, 1985.
Almqvist P.M., Knigge K.M., Kuenzig M., Joseph S.A., Richer W.H., Schwartz S.I. Pulmonary platelet trapping induced by β-endorphin injection in the cerebrospinal fluid in dogs. Surgery 98: 344, 1986.
Ekstrom B.F., Kuwnzig M., Schwartz S.I. Pulmonary platelet trapping in Escherichia coli endotoxin-injected dogs treated with methylpred-nisolone, ibuprofen and naloxone. Acta Chir. Scand. 152: 181, 1986.
Maneckjee R., Minna J.D. Opiod and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. (USA) 87: 3294, 1990.
Author information
Authors and Affiliations
Additional information
This study was supported lin part by a grant from MURST, Fellowship in Internal Medicine
Rights and permissions
About this article
Cite this article
Calogero, A.E., Polosa, R., Neville, E. et al. Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer. J Endocrinol Invest 18, 354–358 (1995). https://doi.org/10.1007/BF03347837
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347837